dc.contributor.author |
Маtsegora, N. A. |
en |
dc.contributor.author |
Shpota, O. E. |
en |
dc.date.accessioned |
2020-02-05T07:04:55Z |
|
dc.date.available |
2020-02-05T07:04:55Z |
|
dc.date.issued |
2018 |
|
dc.identifier.citation |
Matsegora N. A., Shpota O. E. The hypotyresis in patients with chronic obsructive pulmonary disease (COPD) // Journal of Education, Health and Sport. 2018. № 8 (10). P. 357–362. |
en |
dc.identifier.uri |
https://repo.odmu.edu.ua:443/xmlui/handle/123456789/6371 |
|
dc.description.abstract |
The processes of reparative regeneration of the bronchial epithelium are controlled by thymic factors, thyroid hormones, and cellular immunity in patients with COPD in a stage of exacerbation. It complicates by purulent necrotic of the bronchopulmonary system amid a decrease of reduce synthesis of endogenous triiodothyronine. We gave pathophysiological rationale for use of thyroid hormone replacement therapy for correction of hormone (thymalin and thyroid -) dependent functional activity of lymphocytes. We proved the clinical effectiveness of the using alternative triiodothyronine therapy as an extra-immune immunocorrector. It includes thyroid and thymalin-dependent effects in patients with COPD with low triiodothyronine syndrome in the period of exacerbation. |
en |
dc.language.iso |
en |
en |
dc.subject |
COPD |
en |
dc.subject |
thyroid |
en |
dc.subject |
triiodothyronine |
en |
dc.subject |
hypothyreosis |
en |
dc.subject |
fibrinolytic activity |
en |
dc.title |
The hypotyresis in patients with chronic obsructive pulmonary disease (COPD) |
en |
dc.type |
Article |
en |